A trial of clenbuterol in bronchial asthma.
Clenbuterol is a beta 2-sympathomimetic bronchodilator. In a double-blind cross-over trial in 19 asthmatic patients with reversible airways obstruction, oral administration of both clenbuterol (40 microgram) and salbutamol (4 mg) caused significantly greater increased in peak expiratory flow rate (P...
Gespeichert in:
| Veröffentlicht in: | Thorax |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
1977
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC470819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/341407/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.32.6.717 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|